Navigation Links
Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
Date:4/23/2009

SAN DIEGO, April 23 /PRNewswire/ -- Accumetrics, Inc. announces today an exclusive distribution agreement with ELITech UK Limited for distribution of the VerifyNow System in the United Kingdom. The distribution agreement marks the beginning of several new distribution channels for the Company as it expands its reach both in scope and geography. ELITech UK will concentrate its efforts on reaching customers in surgery suites and catheterization labs within UK hospitals and other medical centers.

"We are very pleased to have ELITech UK become our exclusive UK distributor. Their demonstrated expertise in this market and knowledge of our customer base in the UK will help expedite physician access to our products," said Timothy I. Still, President and CEO of the Company. "This partnership marks the beginning of our distribution channel expansion outside the U.S. and demonstrates our focus on rapidly growing our global presence."

"Distribution of the VerifyNow System is extremely complementary to our current portfolio of products, and we are delighted to add them among our customers," said Tim Watson, Managing Director of ELITech UK. "The VerifyNow System is an excellent fit with our expertise within the interventional cardiology market, and we look forward to a long and prosperous partnership with Accumetrics."

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products
'/>"/>

SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
2. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
3. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... of a key segment of DNA can lead to severe ... this kind of genetic alteration can cause obesity. The results ... led by Dr Sadaf Farooqi from the University of Cambridge ... looked at 300 children with severe obesity. , The team ... known as copy number variants (CNVs). CNVs are large chunks ...
(Date:12/6/2009)... Medical College of Wisconsin, in Milwaukee, found a substantial ... cell disease complications in children. Barriers to its use ... also identified. The study led by Amanda M. ... Medical College and Children,s Research Institute at the Children,s ... Society of Hematology meeting Dec. 7, 2009, in New ...
(Date:12/6/2009)... ORLEANS, Dec. 6 Blood clotting, or ... bleeding when a blood vessel is injured. Sometimes, ... without an obvious injury or do not dissolve ... presented today at the 51st Annual Meeting of ... practice of using the anticoagulants aspirin and heparin ...
(Date:12/6/2009)... the Greater VA Healthcare System in West Los Angeles, will once ... soar to more than 5,000 veterans, active military personnel and their ... ... -- Volunteer organizations and members of the community, in cooperation with ... again create a holiday party. This year,s attendance is expected to ...
(Date:12/5/2009)... been significant scientific advances in the field of blood ... understanding of how certain diseases progress in order to ... best care. Research presented today at the 51st Annual ... induction therapies for managing multiple myeloma, the importance of ...
Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8
... MEXICO CITY, Aug. 7 GlaxoSmithKline (NYSE:,GSK) ... clinical trials found,that anti-HIV regimens containing EPZICOM ... regardless of baseline viral loads.,One of the ... treatment with,regimens containing EPZICOM versus regimens containing ...
... People with Crohn,s disease (CD) are seven-fold more likely to ... digestive-tract disease in cattle called Johne,s disease. The role ... is a top research priority, according to a new report ... points out that the cause of CD is unknown, and ...
... Nursing Home Care;,Helps Preserve, Strengthen Intra-Facility Staffing Efforts, ... substantial,benefit in protecting the nation,s critical frontline-caregiver,infrastructure, the ... Susan Collins for helping to lead a successful, ... from moving forward with a new,regulation that would ...
... Aug. 7 Inverness Medical,Innovations, Inc. (Amex: ... and health management solutions, has announced the,introduction of ... the,Determine HIV-1/2 Ag/Ab Combo, at the International AIDS ... be introduced to the developing world,during the third ...
... (August 7, 2008) Embryonic stem cells are ... another type of cell altogether. , It,s a tricky ... handful of key regulators known as "master transcription factors," proteins ... past few years, scientists in the lab of Whitehead Member ...
... dedicated breast MRIs to skyrocket over the next five ... years, according to Millennium Research Group, ... Research,Group,s (MRG) US Markets for Women,s Health Imaging Systems ... covering breast magnetic,resonance imaging (MRI) coils, dedicated breast MRI ...
Other Medicine News:Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 2Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 3Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 4Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 5Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 6Health News:Pathogen that causes disease in cattle also associated with Crohn's disease 2Health News:Senator Susan Collins Praised for Leading Successful Effort to Derail $4.3 Million Maine Medicare Cuts 2Health News:Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo 2Health News:Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo 3Health News:Putting microRNAs on the stem cell map 2Health News:Adjunct Breast Imaging Market to Increase by Almost 28% per Year Through 2013 2
(Date:12/3/2009)... genetic variation that may indicate a patient,s risk of ... certain pharmaceutical therapies or chemicals is one of several ... (NYSE: DGX ) will present during the ... Exposition, December 5-8, 2009, in New Orleans, LA. ...
(Date:12/3/2009)... Dec. 3 BioMed Realty Trust, Inc. (NYSE: ... new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) ... office space at The Landmark at Eastview campus in Tarrytown, ... This lease of additional space was completed approximately two months ...
(Date:12/3/2009)... DIEGO, California, December 3 , ... for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatitis C,Virus ... C Virus , - SPC3649 ... Serious Adverse Events in the Treated Animals - Signaling ...
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Researchers shed light on trading behavior in animals and humans 8746 1Researchers shed light on trading behavior in animals and humans 8746 2Fossil teeth of browsing horse found in Panama Canal earthworks 8744 1Fossil teeth of browsing horse found in Panama Canal earthworks 8744 2New research program BioInterfaces launched 8742 1New research program BioInterfaces launched 8742 2
... Call on Monday, December 10, 2007, NEW HAVEN, ... ) today announced that preliminary data,from its pivotal Phase ... novo acute myelogenous leukemia (AML) would be presented,in a ... Meeting in,Atlanta, Georgia on Saturday, December 8, 2007., ...
... RDYN ) announced today that President and Chief ... and Powerful Anti-infectives,panel at the RBC Capital Markets 2007 ... am ET on Thursday, December 13, 2007 at,the Westin ... audio webcast of the panel discussion will be available ...
Other Medicine Technology:Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting 2Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting 3
... volume Finnpipette Techpette combines form ... performance pipette. Advanced pipetting technology, ... ensures quality, safety, comfort and ... volume range is an important ...
Inquire...
... of moderate viscosity and density. Proven ergonomic design reduces hand fatigue, prevents ... Range (ul) ... 1.0~1.5 Imprecision(%) ... 10 Dimensions: ...
... from Thermo Labsystems was designed specifically to ... features such as the new fast dial ... microvolumes help to define this as a ... new interchangeable handle plate offers a custom ...
Medicine Products: